Pembrolizumab, 25 mg
Order number: 1374853-91-4
Part number: AC100045365
£ 2849.17*
*Prices without VAT and shipping costs£ 3419.00*
*incl. VAT, plus shipping costsPrice Breakdown
This potent immunotherapy agent plays a pivotal role in cancer treatment, offering a targeted approach to managing tumors. By harnessing its potent anti-PD-1 mechanism, Pembrolizumab, 25 Mg facilitates effective disease management.
Product Highlights
- Conveniently packaged in vials, making it suitable for small-scale research or large-scale production needs.
- Compliant with international standards for pharmaceutical-grade research reagents.
- Ideal for laboratory research, development, and quality control applications.
- Suitable for use in various therapeutic areas, including oncology and dermatology.
- Easy integration into existing workflows and protocols.
Designed for Demanding Tasks
This highly concentrated form of Pembrolizumab, 25 Mg is specifically formulated for demanding tasks in cancer therapy, allowing researchers to accurately replicate clinical trial conditions. Its precise formulation enables scientists to investigate the effects of PD-1 inhibition on tumor growth and progression.
Versatile Uses of the Product
- Effective in treating various types of cancers, including melanoma, lung cancer.
- Listed under A to Z with the documented pack details above.
No attributes available
